Hafsa Ahmed

Hafsa Ahmed

Auto-generated profile, based on publicly available information

Hafsa Ahmed

Faculty of Medicine, Dow Medical College Dow University of Health and Sciences Karachi Pakistan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2024 in Health Science Reports
Verified
Journal Article
Open access
HUHamid Ullah
Hamid Ullah
HAHafsa Ahmed
Hafsa Ahmed
ASAriba Salman
Ariba Salman
RIRabia Iqbal
Rabia Iqbal
SHSayed Jawad Hussaini
Sayed Jawad Hussaini
AMAbdullah Malikzai
Abdullah Malikzai
Background: Tuberculosis (TB) remains a major public health concern in Pakistan, which is ranked fifth among high‐burden TB nations worldwide. The growing frequency of drug‐resistant TB strains, particularly multidrug‐resistant TB (MDR‐TB), creates new obstacles. Socioeconomic factors, a lack of awareness, and inadequate healthcare infrastructure all contribute to the spread of the disease.Objective: This study investigates the mechanisms contributing to the growth in tuberculosis cases in Pakistan, the implications for public health, and multifaceted approaches to prevention and control.Methods: A comprehensive literature study was undertaken, including an analysis of peer‐reviewed articles, World Health Organization (WHO) data, and government sources, to identify factors driving tuberculosis prevalence, control issues, and disease‐fighting tactics.Result: Several factors like Poverty, overcrowding, malnutrition, stigma, and restricted access to healthcare services are all factors contributing to an increase in tuberculosis incidence in Pakistan. The prevalence of MDR‐TB, along with a lack of an integrated healthcare response, complicates efforts to contain the disease's spread. Tuberculosis has a profound social, mental, and financial impact on individuals and communities. Public health efforts, such as the National Tuberculosis Control Program (NTP) and international partnerships, have been created to eradicate tuberculosis, although considerable hurdles persist.Objective: This study investigates the mechanisms contributing to the growth in tuberculosis cases in Pakistan, the implications for public health, and multifaceted approaches to prevention and control.

12 April 2023 in Monaldi Archives for Chest Disease
Verified
Journal Article
Open access
PDF file
SAShoaib Ahmad
Shoaib Ahmad
UKUzzam Ahmed Khawaja
Uzzam Ahmed Khawaja
SHSyed Meeran Haider
Syed Meeran Haider
WMWafaa Binti Mowlabaccus
Wafaa Binti Mowlabaccus
AMAnmol Mohan
Anmol Mohan
GYGeorge D Yatzkan
George D Yatzkan
Tuberculosis (TB), at present, is the leading infectious aetiology of death globally. In Pakistan, there are approximately 510,000 new cases annually, with more than 15,000 of them developing into drug resistant TB, making the nation the fifth leading country in TB prevalence in the world. Due to the ongoing COVID-19 pandemic, focus has drifted away from TB screening, diagnostic, health awareness campaigns and therapeutic measures endangering KAP (knowledge, attitude and practices) towards TB in our population. We conducted a cross-sectional descriptive study in Pakistan to assess the knowledge, attitude and practices of Pakistani residents attending the adult outpatient departments of public hospitals for any health-related concern. Our sample size was of 856 participants, with a median age of 22 years. Occupation-wise, those who were employed had better knowledge of TB than those who were unemployed [odds ratio (OR): 1.011; 95% CI :1.005-1.8005]. No differences were observed in TB knowledge between those adherents to common preventive practices versus not adherent (OR 0.875, 95% CI: 0.757-1.403). More than 90 % of participants agreed that TB is dangerous for the community and a majority opted against stigmatising TB patients (79.1%). People who could read and write were 3.5 times more likely to have a good attitude towards TB compared to those who could not (OR: 3.596;95% CI: 1.821–70.230; p=0.037). Similarly, employed subjects had better attitude compared to unemployed ones (p=0.024), (OR: 1.125; 95% CI: 0.498, 1.852) and those having better knowledge of TB had a better attitude grade (OR:1.749; 95% CI: 0.832–12.350), p=0.020). Age, occupation, and educational status were statistically significant among the two groups (p=0.038, p=0.023, p=0.000) respectively. Literate subjects had thrice good practice towards TB than illiterate (OR: 3.081; 95% CI: 1.869–4.164; p=0.000). Future education and awareness programs should target specific groups such as the unemployed and illiterate with practice-focused approaches. Our study outcomes can enable the concerned officials and authorities taking appropriate evidence-based steps to direct the efforts in an efficient manner to curtail the burden of TB in Pakistan and to limit its progression that could potentially lead our nation to become an MDR-TB endemic territory.

28 November 2023 in Journal of the Pakistan Medical Association
Verified
Journal Article
Open access
PDF file
HAHafsa Ahmed
Hafsa Ahmed
HAHamidullah
Hamidullah
Dear editor, Acetaminophen is the most widely used pain relief medication around the globe. It is used as an antipyretic and treat various medical ailments, including mild to moderate pain [1]. However, studies have shown that acetaminophen is associated with several adverse consequences, among which hepatotoxicity is the most pronounced [2]. However, despite its well know side-effects and risk of hepatotoxicity, acetaminophen is widely prescribed and its overdosing is a serious issue. Moreover, many combination of medications prescribed for pain relief do contain acetaminophen as its component. Often a single dose of such combinations contains two or more drugs of which many recipient remain ignorant that they are ingesting acetaminophen in the prescribed combination of drugs. This ignorance can lead to overdosing of acetaminophen and subsequent risk of hepatotoxicity [3]. On January 13, 2011, the U.S FDA addressed this issue by asking manufacturers to limit acetaminophen dosage from 750 mg/tablet to 325 mg/tablet in combination acetaminophen and opioid medications. The U.S FDA also asked all its manufacturers to place a box warning on all the combination medications that contain acetaminophen as its component, stating its association with liver injury [4]. A recent study published in JAMA, March 2023, further authenticated this ruling [5]. The study assessed the impact of U.S FDA’s decision to limit the amount of acetaminophen dose to 325 mg/tablet in prescription combination opioid drugs on the incidence of subsequent hospitalization and acute liver failure. It was found that predicted incidence of hospitalization, a day prior to FDA announcement was 12.2 cases/ 100000 hospitalizations whereas in 2019 it was reduced to 4.4 cases/ 100000 hospitalizations. Prior to the announcement the percentage of acute liver failure caused by acetaminophen and opioid toxicity rose by 07% per year and it fell by 16% annually after the announcement. Hence, it was concluded that U.S FDA’s decision of limiting acetaminophen dosage to 325 mg/tablet in combination drugs helped in reducing the incidents of acetaminophen related hepatotoxicity [5]. The above stated study showed satisfying statistics regarding the decline hepatotoxicity with lower doses of acetaminophen in prescription combination drugs. However, the matter is still not totally resolved because the U.S FDA’s decision of reducing acetaminophen dosage was limited to the prescription combination medications and excluded the acetaminophen drugs available over-the-counter. ---Continue